Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

washingtonpost.com

1 of 0

Resource Description:

Rockville-based Human Genome Sciences announced Monday that its experimental lupus drug has completed its final round of testing at a higher dose and will be headed to the Food and Drug Administration for approval.

« Back to the New Lupus Drug Shows Promise WisdomCard

Related Health Centers:

Advertisement